Characterising metabolomic signatures of lipid-modifying therapies through drug target mendelian randomisation
Open accessPublished version of a preprint
The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
Large-scale molecular profiling and genotyping provide a unique opportunity to systematically compare the genetically predicted effects of therapeutic targets on the human metabolome. We firstly constructed genetic risk scores for 8 drug targets on the basis that they primarily modify low-density lipoprotein (LDL) cholesterol (HMGCR, PCKS9, and NPC1L1 ) , high-density lipoprotein (HDL) cholesterol (CETP), or triglycerides (APOC3, ANGPTL3, ANGPTL4, and LPL). Conducting mendelian randomisation (MR) provided strong evidence of an effect of drug-based genetic scores on coronary artery disease (CAD) risk with the exception of ANGPTL3. We then systematically estimated the effects of each score on 249 metabolic traits derived using blood samples from an unprecedented sample size of up to 115,082 UK Biobank participants. Genetically predicted effects were generally consistent among drug targets, which were intended to modify the same lipoprotein lipid trait. For example, the linear fit for the MR estimates on all 249 metabolic traits for genetically predicted inhibition of LDL cholesterol lowering targets HMGCR and PCSK9 was r 2 = 0.91. In contrast, comparisons between drug classes that were designed to modify discrete lipoprotein traits typically had very different effects on metabolic signatures (for instance, HMGCR versus each of the 4 triglyceride targets all had r 2 < 0.02). Furthermore, we highlight this discrepancy for specific metabolic traits, for example, finding that LDL cholesterol lowering therapies typically had a weak effect on glycoprotein acetyls, a marker of inflammation, whereas triglyceride modifying therapies assessed provided evidence of a strong effect on lowering levels of this inflammatory biomarker. Our findings indicate that genetically predicted perturbations of these drug targets on the blood metabolome can drastically differ, despite largely consistent effects on risk of CAD, with potential implications for biomarkers in clinical development and measuring treatment response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Genetically proxied levels of lipids were significantly associated with CAD33,34”
From Genetic insights into causal effects of lipids and lipid-modifying targets on calcific aortic valve stenosis: a Mendelian randomized study (2025) · cites this paper as [33]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ggplot2: Elegant Graphics for Data Analysis
Ginestet, C. (2011) · Journal of the Royal Statistical Society Series A: Statistics in Society · doi:10.1111/j.1467-985x.2010.00676_9.x · Cited by 13,726 · cited 1×
“All plots in this study were generated using the R package “ggplot2” [52].”
Sudlow, C., Gallacher, J., Allen, N., Beral, V., Burton, P., Danesh, J., Downey, P., Elliott, P., Green, J., Landray, M., et al. (2015) · PLOS Medicine · doi:10.1371/journal.pmed.1001779 · Cited by 12,728 · cited 1×
“Genetic instruments for each lipid-modifying drug target were selected by undertaking GWAS of lipoprotein lipid traits measured using a conventional biochemistry assay in UKB [44].”
The UK Biobank resource with deep phenotyping and genomic data
Bycroft, C., Freeman, C., Petkova, D., Band, G., Elliott, L. T., Sharp, K., Motyer, A., Vukcevic, D., Delaneau, O., O’Connell, J., et al. (2018) · Nature · doi:10.1038/s41586-018-0579-z · Cited by 8,876
An integrated map of genetic variation from 1,092 human genomes
The 1000 Genomes Project Consortium (2012) · Nature · doi:10.1038/nature11632 · Cited by 7,711 · cited 1×
“We conducted linkage disequilibrium (LD) pruning for variants such that they had r 2 0.1 using a reference panel of 503 European individuals enrolled in the 1,000 Genomes Project phase 3 (version 5) [47].”
InfluentialMendelian Randomization Analysis With Multiple Genetic Variants Using Summarized Data
Burgess, S., Butterworth, A., & Thompson, S. G. (2013) · Genetic Epidemiology · doi:10.1002/gepi.21758 · Cited by 6,050 · cited 2×
“Two-sample MR analyses were undertaken using the inverse variance weighted (IVW) method while accounting for the correlation between instruments [22,23] ( Fig 1 ).”
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
Cannon, C. P., Blazing, M. A., Giugliano, R. P., McCagg, A., White, J. A., Theroux, P., Darius, H., Lewis, B. S., Ophuis, T. O., Jukema, J. W., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1410489 · Cited by 4,487
Ference, B. A., Ginsberg, H. N., Graham, I., Ray, K. K., Packard, C. J., Bruckert, E., Hegele, R. A., Krauss, R. M., Raal, F. J., Schunkert, H., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx144 · Cited by 3,962
A comprehensive 1000 Genomes–based genome-wide association meta-analysis of coronary artery disease
the CARDIoGRAMplusC4D Consortium (2015) · Nature Genetics · doi:10.1038/ng.3396 · Cited by 2,447
Interpretation of the evidence for the efficacy and safety of statin therapy
Collins, R., Reith, C., Emberson, J., Armitage, J., Baigent, C., Blackwell, L., Blumenthal, R., Danesh, J., Smith, G. D., DeMets, D., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31357-5 · Cited by 1,857 · cited 1×
“Circulating lipoprotein lipid concentrations are of central importance to the aetiology of CAD [2,3].”
Mahajan, A., Taliun, D., Thurner, M., Robertson, N. R., Torres, J. M., Rayner, N. W., Payne, A. J., Steinthorsdottir, V., Scott, R. A., Grarup, N., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0241-6 · Cited by 1,744 · cited 1×
“Genetic estimates on T2D were extracted from a previous GWAS from the DIAMANTE consortium consisting of 74,124 cases and 824,006 controls of European ancestry [50].”
Research works printed but not linked: 1
- Mendes PFAPP Moura JMSP, 2020, New drugs coming up in the field of lipid control, e-Journal of Cardiology. Practice, 19
Cited by
Atlas of plasma NMR biomarkers for health and disease in 118,461 individuals from the UK Biobank
Julkunen, H., Cichońska, A., Tiainen, M., Koskela, H., Nybo, K., Mäkelä, V., Nokso-Koivisto, J., Kristiansson, K., Perola, M., Salomaa, V., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36231-7 · Cited by 536
Genome-wide characterization of circulating metabolic biomarkers
Karjalainen, M. K., Karthikeyan, S., Oliver-Williams, C., Sliz, E., Allara, E., Fung, W. T., Surendran, P., Zhang, W., Jousilahti, P., Kristiansson, K., et al. (2024) · Nature · doi:10.1038/s41586-024-07148-y · Cited by 261
Short Chain Fatty Acid Metabolism in Relation to Gut Microbiota and Genetic Variability
Ramos Meyers, G., Samouda, H., & Bohn, T. (2022) · Nutrients · doi:10.3390/nu14245361 · Cited by 184
Mansour, A., Mousa, M., Abdelmannan, D. K., Tay, G. K., Hassoun, A. A. K., & AlSafar, H. S. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1143067 · Cited by 178
Li, Z., Zhang, B., Liu, Q., Tao, Z., Ding, L., Guo, B., Zhang, E., Zhang, H., Meng, Z., Guo, S., et al. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104543 · Cited by 148
Mendelian randomization: causal inference leveraging genetic data
Chen, L. G., Tubbs, J. D., Liu, Z., Thach, T., & Sham, P. C. (2024) · Psychological Medicine · doi:10.1017/s0033291724000321 · Cited by 99
“Furthermore, MR is increasingly being applied to a wide range of multi-omics data, including metabolomics (Liu et al., 2017; Richardson et al., 2022), epigenetic markers (Alameda et al., 2022; Jamieson et al., 2020; Richardson et al., 2019), single-cell transcriptomics (Haglund et al., 2022), and…”
BackgroundDyslipidemia and Risk of Preeclampsia: A Multiancestry Mendelian Randomization Study
Hosier, H., Lipkind, H. S., Rasheed, H., DeWan, A. T., & Rogne, T. (2023) · Hypertension · doi:10.1161/hypertensionaha.122.20426 · Cited by 57
The Physiological and Pathological Role of Acyl-CoA Oxidation
Szrok-Jurga, S., Czumaj, A., Turyn, J., Hebanowska, A., Świerczyński, J., Śledziński, T., & Stelmańska, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914857 · Cited by 62
Cummings, B. B., Joing, M. P., Bouchard, P. R., Milton, M. N., Moesta, P. F., Ramanan, V., Lane, A., Hirman, J., Trauger, J. W., Maratos-Flier, E., et al. (2025) · The Lancet · doi:10.1016/s0140-6736(25)00825-6 · Cited by 49
Landfors, F., Henneman, P., Chorell, E., Nilsson, S. K., & Kersten, S. (2024) · European Heart Journal Open · doi:10.1093/ehjopen/oeae035 · Cited by 42
“In line with a previous investigation, 46 we found no significant association between ANGPTL3 inactivation via common variants and CAD.”
BackgroundResultMultiomics in atherosclerotic cardiovascular disease
Nordestgaard, L. T., Wolford, B. N., de Gonzalo‐Calvo, D., Sopić, M., Devaux, Y., Matic, L. P., Wettinger, S. B., Schmid, J. A., Amigó, N., Masana, L., et al. (2025) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2025.120414 · Cited by 41
Wadström, B. N., Pedersen, K. M., Wulff, A. B., & Nordestgaard, B. G. (2024) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.123.320175 · Cited by 35
“Variables located on the biological pathway of remnants and LDL, namely body mass index, diabetes, and atherosclerotic cardiovascular disease, were purposely not adjusted for in main analyses but were adjusted for in sensitivity analyses.”
BackgroundInfluentialHu, Y., Wang, X., Lin, L., Huan, J.-M., Li, Y., Zhang, L., & Li, Y. (2023) · Lipids in Health and Disease · doi:10.1186/s12944-023-01882-4 · Cited by 32
“The TC, LDL-C, and HDL-C values were acquired through high-throughput nuclear magnetic resonance metabolomics conducted by Nightingale Health (biomarker quantification version 2020) [29].”
MethodMetabolic reprogramming in cancer: signaling pathways and therapeutic targets
Dong, S., & Lei, X. (2026) · Molecular Cancer · doi:10.1186/s12943-026-02582-0 · Cited by 40
“The acquisition of exogenous lipids is important for the synthesis of cholesterol and FAs, where cholesterol maintains the integrity and fluidity of the cell membrane and affects the composition of membrane microstructures [196].”
Mayerhofer, E., Malik, R., Parodi, L., Burgess, S., Harloff, A., Dichgans, M., Rosand, J. M., Anderson, C. D., & Georgakis, M. K. (2022) · Brain · doi:10.1093/brain/awac186 · Cited by 31
“43 As demonstrated in our analyses but also in previous work, 44 statins in fl uence a wide range of lipoprotein particles beyond LDL and thus revealing the main driver of their association with ICH remains a key challenge.”
[Incisional hernia after surgery for abdominal aortic aneurysm].
Augestad, K. M., Wilsgaard, T., & Solberg, S. K. (2002) · Tidsskrift for Den Norske Laegeforening · Cited by 41
Genetic analysis of circulating metabolic traits in 619,372 individuals
Tambets, R., Jesse, M., Kronberg, J., van der Graaf, A., Abner, E., Võsa, U., Rahu, I., Taba, N., Kolde, A., Yarish, D., et al. (2026) · Nature · doi:10.1038/s41586-026-10532-5 · Cited by 37
“A promising alternative to genome-wide Mendelian randomization is cis -Mendelian randomization that focuses the analysis to a specific cis region around the target gene of interest 9,51 .”
InfluentialGenetic regulatory effects in response to a high-cholesterol, high-fat diet in baboons
Lin, W., Wall, J. D., Li, G., Newman, D., Yang, Y., Abney, M., VandeBerg, J. L., Olivier, M., Gilad, Y., & Cox, L. A. (2024) · Cell Genomics · doi:10.1016/j.xgen.2024.100509 · Cited by 33
“38 41 This non-coding SNP of APOA2 (rs5082) shows a significant positive association with BMI in three independent cohorts of European and Hispanic individuals with high saturated fat intake (>22 g/day) (Figure 3C).”
Xu, H., Wang, X., Xu, X., Liu, L., Zhang, Y., Yan, X., Zhang, Y., Dang, K., & Li, Y. (2023) · Clinical Nutrition · doi:10.1016/j.clnu.2023.10.019 · Cited by 28
Fang, S., Holmes, M. V., Gaunt, T. R., Smith, G. D., & Richardson, T. G. (2022) · eLife · doi:10.7554/elife.73951 · Cited by 29
Self-citationOmega-3 Fatty Acids as Protective Factors for Age-Related Macular Degeneration
Xue, C. C., Li, H., Yu, M., Chong, C. C. Y., Fan, Q., Tham, Y. C., Cheung, C. M. G., Wong, T. Y., Chew, E. Y., & Cheng, C. (2024) · Ophthalmology · doi:10.1016/j.ophtha.2024.12.005 · Cited by 24
Landfors, F., Chorell, E., & Kersten, S. (2022) · Journal of Lipid Research · doi:10.1016/j.jlr.2022.100313 · Cited by 25
“ANGPTL, angiopoietin-like protein; ASCVD, atherosclerotic cardiovascular disease; EL, endothelial lipase; eQTL, expression quantitative trait loci; GWAS, genome-wide association study; IV, instrumental variable; LD, linkage disequilibrium; LDLR, LDL receptor; LIPC, lipase C hepatic type; LIPG, lipase G endothelial typ…”
BackgroundMethodInfluentialWei, Y., Hägg, S., Mak, J. K. L., Tuomilehto, J., Zhan, Y., & Carlsson, S. (2024) · European Journal of Epidemiology · doi:10.1007/s10654-024-01117-5 · Cited by 28
“The MR analyses were based on 94 independent SNPs as instrumental variables (IV) for smoking initiation in Europeans [29], and summary statistics for the SNP-metabolite associations from a recent genome-wide association study (GWAS) of metabolomics in UKB [30 ] (eMethod 1; eTable 2).”
MethodBranched‐chain amino acids and type 2 diabetes: a bidirectional Mendelian randomization analysis
Mosley, J. D., Shi, M., Agamasu, D., Vaitinadin, N. S., Murthy, V. L., Shah, R. V., Bagheri, M., & Ferguson, J. F. (2024) · Obesity · doi:10.1002/oby.23951 · Cited by 26
“Recent large-scale genome-wide association studies (GWAS) of BCAAs have identified considerably more loci associated with the BCAAs, providing an opportunity to investigate etiological relationships using robust predictors that represent heterogenous genetic mechanisms modulating BCAA levels [16].”
BackgroundMethodHou, T., Dai, H., Wang, Q., Hou, Y., Zhang, X., Lin, H., Wang, S., Li, M., Zhao, Z., Lu, J., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1148591 · Cited by 24
“Summary statistics for blood DHA and PUFAs were from the largest GWAS for metabolites in the UK Biobank, including 114,999 European participants (23).”
BackgroundSelf-citationLouck, L. E., Cara, K. C., Klatt, K. C., Wallace, T. C., & Chung, M. (2023) · Advances in Nutrition · doi:10.1016/j.advnut.2023.100164 · Cited by 22
“The key fi ndings from our search extend other work reporting on single nucleotide polymorphisms associated with dietary choline de fi - ciency [16], reporting on several genetic variant associations with lower circulating choline concentrations [27,38,43,47].”
BackgroundLiu, C., & Gershon, E. S. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-03195-1 · Cited by 27
Harnessing the Power of Electronic Health Records and Genomics for Drug Discovery
Krebs, K., & Milani, L. A. (2023) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-051421-111324 · Cited by 20
Shen, X., Barbu, M. C., Caramaschi, D., Arathimos, R., Czamara, D., David, F. S., Dearman, A., Dilkes, E., Herrera-Rivero, M., Huider, F., et al. (2025) · Nature Mental Health · doi:10.1038/s44220-025-00486-4 · Cited by 25
“…and PH149 67,68 inventories of the Health Data Research UK Phenotype Library for primary care data of depression were used to identify cases of lifetime MD. Participants with ≥1 entry of diagnosis of depression were classified as cases, and those with no entry of any diagnosis for depression or…”
Self-citationLeveraging osteoclast genetic regulatory data to identify genes with a role in osteoarthritis
Mullin, B. H., Zhu, K., Brown, S. J., Mullin, S., Dudbridge, F., Pavlos, N. J., Richards, J. B., Grundberg, E., Bell, J. T., Zeggini, E., et al. (2023) · Genetics · doi:10.1093/genetics/iyad150 · Cited by 20
“This SNP is an intronic variant in the gastric inhibitory polypeptide receptor ( GIPR ) gene and has previously been identified as associated with several lipid ratio traits and type 2 diabetes at the genome-wide level (Mahajan et al. 2018; Richardson et al. 2022).”
BackgroundSelf-citationHodonsky, C. J., Turner, A. W., Khan, M. D., Barrientos, N. B., Methorst, R., Ma, L., Lopez, N. G., Mosquera, J. V., Auguste, G. E., Farber, E., et al. (2023) · Cell Genomics · doi:10.1016/j.xgen.2023.100465 · Cited by 25
Omega-3 Polyunsaturated Fatty Acids as a Protective Factor for Myopia
Xue, C. C., Li, H., Dong, X., Yu, M., Soh, Z. D., Chong, C. C. Y., Jiang, C., Choquet, H., Zebardast, N., Zekavat, S. M., et al. (2024) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2024.08.041 · Cited by 20
Li, J., Yuan, Z., Li, J., Liu, Z., Wang, Y., Cui, M., Suo, C., Li, J., Ding, D., Chen, X., et al. (2025) · Biomarker Research · doi:10.1186/s40364-025-00851-6 · Cited by 20
“Metabolic data were obtained from the UK Biobank (249 metabolic traits, N = 115,082) [28].”
Qu, K., Li, M., Gan, L., Cui, Z.-T., Li, J., Yang, R., & Dong, M. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1325047 · Cited by 21
Impact of Remnant Cholesterol on Cardiovascular Risk in Diabetes
Elías-López, D., Wadström, B. N., Vedel‐Krogh, S., Kobylecki, C. J., & Nordestgaard, B. G. (2024) · Current Diabetes Reports · doi:10.1007/s11892-024-01555-1 · Cited by 18
“Indeed, genetic variation in LPL , which leads to increased levels of plasma triglycerides, is associated with increased risk of ASCVD in the general population [50, 56–59].”
Elevated Remnant and LDL Cholesterol and the Risk of Peripheral Artery Disease
Wadström, B. N., Borges, M. C., Wulff, A. B., Smith, G. D., Sanderson, E. C. M., & Nordestgaard, B. G. (2025) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.12.033 · Cited by 19
Remnant cholesterol traits and risk of stroke: A multivariable Mendelian randomization study
Wu, Z., Jiang, Y., Guo, Z., Li, P., Zheng, Y., Wang, Y., Zhang, H., Balmer, L. A., Li, X., Tao, L., et al. (2024) · PNAS Nexus · doi:10.1093/pnasnexus/pgae033 · Cited by 18
“…single-nucleotide polymorphisms (SNPs) previously shown to be associated with the remnant cholesterol traits (remnant cholesterol, IDL cholesterol, and VLDL cholesterol) at the level of genome-wide significance ( P 5 × 10 − 8 ) among 115,082 UK Biobank participants of European ancestry (18).”
BackgroundMethodModder, M., Panhuis, W. I. H., Li, M., Afkir, S., Dorn, A. L., Pronk, A. C. M., Streefland, T. C. M., Lalai, R. A., Pierrou, S. E., Nilsson, S. K., et al. (2024) · Cardiovascular Research · doi:10.1093/cvr/cvae195 · Cited by 19
Luo, S., Zheng, M., Wong, V. W., & Yeung, S. L. A. (2024) · eGastroenterology · doi:10.1136/egastro-2024-100114 · Cited by 19
“38 Of note, it is plausible that targeting the same phenotype via different mechanisms can yield varying effects on outcomes.”
The Lipidomic Profile Discriminates Between MASLD and MetALD
Schneider, K. M., Cao, F., Huang, H. Y. R., Chen, L., Chen, Y., Gong, R., Raptis, A. A., Creasy, K. T., Clusmann, J., van Haag, F., et al. (2025) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.70012 · Cited by 20
“Data of alcohol consumption and metabolites were obtained from two large genome-wide association studies (GWAS) in populations of European ancestry [20, 21].”
Misganaw, B., Yang, R., Gautam, A., Muhie, S. Y., Mellon, S. H., Wolkowitz, O. M., Ressler, K. J., Doyle, F. J., Marmar, C. R., Jett, M., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012504 · Cited by 18
“70% [57] Sugar related Glucose (GIANT) fasting blood glucose 200,622 8.”
BackgroundLipid metabolites are associated with the risk of osteoporotic fractures
Shao, L., Luo, S., & Zhao, Z. (2024) · Scientific Reports · doi:10.1038/s41598-024-69594-y · Cited by 17
“These data are now available to approved researchers through the UK Biobank for use in all aspects of public health 31,32 .”
MethodKhan, S. R., Ye, W. W., Van, J. A. D., Singh, I., Rabiee, Y., Rodricks, K. L., Zhang, X., Nicholson, R. J., Razani, B., Summers, S. A., et al. (2025) · Science Advances · doi:10.1126/sciadv.adr1725 · Cited by 18
Wang, Z., Chen, S., Zhang, F., Akhmedov, S., Weng, J., & Xu, S. (2025) · Research · doi:10.34133/research.0618 · Cited by 22
“…n = 361,194) [ 33 ], Coronary artery disease (ID: ebi-a-GCST90013864, n = 352,063) [ 34 ], HDL cholesterol (ID: ieu-b-109, n = 403,943) [ 35 ], Heart failure (ID: ebi-a-GCST009541, n = 977,323)[ 36 ], Hyperlipidemia (ID: ebi-a-GCST90104006, n = 349,222) [ 37 ], Hypertension (ID:…”
Jang, S.-J., Tuan, W.-L., Hsu, L., Er, L., Teng, M., Wu, S., & Ko, Y. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314963 · Cited by 18
“A GWAS study determined that APOB rs693 genotypes were associated with remnant cholesterol levels [37].”
BackgroundWadström, B. N., Pedersen, K. M., Wulff, A. B., & Nordestgaard, B. G. (2023) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000867 · Cited by 17
An in-depth review of AI-powered advancements in cancer drug discovery
Le, M. H. N., Nguyen, P. K., Nguyen, T. P. T., Nguyen, H. Q., Tam, D. N. H., Huynh, H. H., Huynh, P. K., & Le, N. Q. K. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.167680 · Cited by 15
Mitochondrial related variants associated with cardiovascular traits
Cañadas‐Garre, M., Maqueda, J. J., Baños‐Jaime, B., Hill, C., Skelly, R., Cappa, R., Brennan, E. P., Doyle, R., Godson, C., Maxwell, A. P., et al. (2024) · Frontiers in Physiology · doi:10.3389/fphys.2024.1395371 · Cited by 17
Xu, F., Albadry, M., Döding, A., Chen, X., Dirsch, O., Schulze‐Späte, U., & Dahmen, U. (2024) · European Journal of Nutrition · doi:10.1007/s00394-024-03560-2 · Cited by 16
Tale of two systems: the intertwining duality of fibrinolysis and lipoprotein metabolism
Dai, W., Castleberry, M., & Zheng, Z. (2023) · Journal of Thrombosis and Haemostasis · doi:10.1016/j.jtha.2023.08.004 · Cited by 15
GPAT1 Deficiency in Mice Modulates NASH Progression in a Model-Dependent Manner
Smith, K. R., Wang, W., Miller, M. R., Boucher, M., Reynold, J. E., Daurio, N. A., Li, D., Hirenallur-Shanthappa, D. K., Ahn, Y., Beebe, D. A., et al. (2023) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2023.10.002 · Cited by 17
“However, it is worth noting that the GPAM I43V variant is associated with lower circulating ketone levels 33 and elevated liver fat, arguing that the regulation of hepat-ic fatty acid oxidation and ketogenesis by GPAT1 could be part of the mechanisms for its role of NASH and liver injury in humans.”
BackgroundMetabolic liability for weight gain in early adulthood
Murthy, V. L., Mosley, J. D., Perry, A., Jacobs, D. R., Tanrıverdi, K., Zhao, S., Sawicki, K. T., Carnethon, M. R., Wilkins, J. T., Nayor, M. G., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101548 · Cited by 14
Qiu, S., Liu, Z., Jiang, W., Sun, J.-H., Liu, Z.-Q., Sun, X., Wang, C., & Liu, W. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02266-3 · Cited by 14
“Blood samples from 113,594 UK Biobank participants were utilized to test 3-hydroxybutyrate levels using genome-wide genotyping array [26].”
MethodHe, X., Zhang, Z., Jiang, H., Luo, H., Gan, Q., Wei, K., Liu, Y., Qin, Y., & Xiao, M. (2024) · Scientific Reports · doi:10.1038/s41598-024-78603-z · Cited by 15
“The data for 249 blood metabolites were collected from the UK Biobank GWAS of 115,082 individuals of European descent 13 .”
MethodAn ANGPTL4 inhibitory antibody safely improves lipid profiles in non-human primates
Cummings, B. B., Bouchard, P. R., Milton, M., Moesta, P. F., Ramanan, V., Trauger, J. W., Maratos–Flier, E., Voznesensky, A., Splawski, I., Nimonkar, A. V., et al. (2025) · EBioMedicine · doi:10.1016/j.ebiom.2025.105748 · Cited by 17
Lou, C., Meng, Z., Shi, Y., Zheng, R., Qian, S., & Pan, J. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1217922 · Cited by 14
Gu, Y., Ye, X., Zhao, W., He, S., Zhang, W., & Zeng, X. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1379130 · Cited by 14
Zhu, H., Han, X., Li, L., Yang, M., Lin, Y., Zhou, J., Zhang, X., Zhou, Y., Lan, X., Liu, J., et al. (2024) · Cell Genomics · doi:10.1016/j.xgen.2024.100631 · Cited by 15
Venkataraghavan, S., Pankow, J. S., Boerwinkle, E., Fornage, M., Selvin, E., & Ray, D. (2025) · Diabetologia · doi:10.1007/s00125-024-06352-9 · Cited by 13
“Variants near GPX6 are linked to HbA 1c [60] BMI-adjusted waist circumference [61] and lipids [62], and circulating glutathione peroxidase protein levels are suppressed in individuals with vs without diabetes [58].”
Wadström, B. N., Wulff, A. B., Pedersen, K. M., & Nordestgaard, B. G. (2024) · Clinical Chemistry · doi:10.1093/clinchem/hvae222 · Cited by 13
Kalwick, M., & Roth, M. M. (2025) · Nutrients · doi:10.3390/nu17040659 · Cited by 20
Qiu, J., Hu, P., Li, F., Huang, Y., Yang, Y., Sun, F., Wu, P., Lai, Y., Wang, Y., He, X., et al. (2025) · BMC Medicine · doi:10.1186/s12916-025-04061-7 · Cited by 12
“GWAS data for LA were obtained from the IEU OpenGWAS database (https:// gwas. mrcieu. ac. uk/, GWAS IDs: ebi-a-GCST90092881), comprising 115,006 participants from European ancestry [28].”
Yuan, F., Jia, G., Wen, W., Xu, S., Gunchick, V., Deng, K., Long, J., Yu, D., Shu, X., & Zheng, W. (2025) · British Journal of Cancer · doi:10.1038/s41416-025-02997-4 · Cited by 12
“In total, among 694 independent variants associated with any of these biomarkers at a P -value 5 × 10 − 8 , 323 variants had not been previously reported [25].”
Nordestgaard, L. T., Hanson, A., Sanderson, E. C. M., Anderson, E. L., Walker, V. M., Tybjærg‐Hansen, A., Smith, G. D., & Nordestgaard, B. G. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70638 · Cited by 13
“…levels of triglycerides (as a marker of triglyceride-rich lipoproteins such as very-low-density lipoprotein and intermediate-density lipoproteins) 28,29 initial analyses have been performed using LDL cholesterol and triglycerides as exposures (instrumented by variants in these drug target genes).”
Zhang, T., Chen, Y., Li, X., Zhang, J., & Duan, L. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1279266 · Cited by 12
Artificial intelligence in drug development for delirium and Alzheimer’s disease
Ai, R., Xiao, X., Deng, S., Yang, N., Xing, X., Watne, L. O., Selbæk, G., Wedatilake, Y., Xie, C., Rubinsztein, D. C., et al. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.04.026 · Cited by 13
“Furthermore, they facilitate discovery of biomarkers for predicting disease onset, tracking disease progression and assessing drug efficacy in clinical trials 86,87 .”
Do Triglyceride-Rich Lipoproteins Equal Low-Density Lipoproteins in Risk of ASCVD?
Wadström, B. N., Wulff, A. B., Pedersen, K. M., & Nordestgaard, B. G. (2023) · Current Atherosclerosis Reports · doi:10.1007/s11883-023-01153-8 · Cited by 13
Li, M., Liu, Q., Shi, M., Fu, M., & He, G. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-024-02241-7 · Cited by 13
“Following the steps above, these measurements were rigorously account for variables such as age, gender, fasting condition, and genetic profile data to ensure statistical validity and enhance the analysis’ precision [22].”
MethodLin, C., Xia, M., Dai, Y., Huang, Q., Sun, Z., Zhang, G., Luo, R., Peng, Q., Li, J., Wang, X., et al. (2025) · Cell Genomics · doi:10.1016/j.xgen.2025.100810 · Cited by 14
Chen, S., Zhang, M., Yang, P., Guo, J., Liu, L., Yang, Z., & Nan, K. (2024) · Journal of Lipids · doi:10.1155/2024/5324127 · Cited by 11
“(GWAS ID: ieu-a-300) [26], HDL-C (GWAS ID: ieu-b-109) [27], and TG (ieu-b-111 and ebi-a-GCST90092829) [27, 28] were obtained from the IEU OpenGWAS project [29].”
MethodRegulation of Mitochondria-Derived Immune Activation by ‘Antiviral’ TRIM Proteins
Oh, S., & Mandell, M. A. (2024) · Viruses · doi:10.3390/v16071161 · Cited by 11
Yang, X., Huang, L., Zhang, Y., Wang, K., Liu, S., Li, X., Ding, Y., Deng, D., Zhang, T., Zhao, W., et al. (2024) · Clinical Nutrition · doi:10.1016/j.clnu.2024.07.039 · Cited by 11
Shine, B.-K., Choi, J., Park, Y., & Hong, K. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252312690 · Cited by 10
Ge, A., Sun, Y., Kiker, T., Zhou, Y., & Ye, K. (2023) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2023.578105 · Cited by 11
“The effect sizes in met-c and met-d were already standardized to SD because of the inverse rankbased normal transformation of phenotypic values before GWAS (Kettunen et al., 2016; Richardson et al., 2022).”
Luo, S., Lam, H. S., Chan, Y. H., Tang, C. S.-M., He, B., Kwok, M. K., Leung, G. M., Schooling, C. M., & Yeung, S. L. A. (2023) · BMC Medicine · doi:10.1186/s12916-023-03115-y · Cited by 10
Li, S., Spitz, N., Ghantous, A., Abrishamcar, S., Reimann, B., Marques, I. F., Silver, M. J., Aguilar-Lacasaña, S., Kitaba, N. T., Rezwan, F. I., et al. (2024) · Communications Biology · doi:10.1038/s42003-023-05698-x · Cited by 11
“…associated with metabolism-related traits in many GWAS studies (low density lipoprotein cholesterol measurement 46,47 , total cholesterol measurement 46,47 , linoleic acid measurement 48 , omega-6 polyunsaturated fatty acid measurement 48,49 , and HMG CoA reductase inhibitor use measurement 50 ).”
Unraveling the causal link: fatty acids and inflammatory bowel disease
Zhou, Y., & Zhou, Z. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1405790 · Cited by 9
Hong, K. U., Walls, K. M., & Hein, D. W. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1091976 · Cited by 13
Aldridge, C., Braun, R. G., Keene, K. L., Hsu, F., & Worrall, B. B. (2023) · Neurology · doi:10.1212/wnl.0000000000207716 · Cited by 14
Han, G., Wei, P., He, M., Jia, L., Su, Q., Yang, X., & Hao, R. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-024-02197-8 · Cited by 8
“The original studies obtained ethical approval and informed consent and therefore no additional approval was required [21].”
BackgroundKim, B. R., Kim, G., Jin, S., Choi, C. W., Kim, J.-H., & Park, H. (2025) · British Journal of Dermatology · doi:10.1093/bjd/ljaf052 · Cited by 9
Xia, X., Tie, X., Hong, M., & Yin, W. (2025) · Thrombosis Journal · doi:10.1186/s12959-025-00700-4 · Cited by 9
“GCST90092807 was derived from research conducted by Richardson TG et al., which focused on assessing the genetic predictive impact of therapeutic targets on the human metabolome [15].”
Mathialagan, S., Chung, G., Pye, K., Rodrigues, A. D., Varma, M. V. S., & Brown, C. (2023) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.123.001890 · Cited by 8
“The observed SLC22A7 genotype effect is limited to one report and has not been confirmed elsewhere, while associations between SLC22A2 gene variants and SCr/eGFR were found in several independent studies (Pattaro et al., 2016; Barton et al., 2021; Richardson et al., 2022).”
ResultYu, X., Shen, G., Zhang, Y., Cui, C., Zha, Y., Li, P., Li, L., Wang, X., & Nan, G. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1404234 · Cited by 10
Genetics of remnant cholesterol
Wulff, A. B., & Nordestgaard, B. G. (2025) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000991 · Cited by 8
Hu, G., Song, C., Yang, Y., Wang, W., Wang, A., Huang, M., Lei, L., & Wu, Y. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1214232 · Cited by 9
“Also, it included five circulating lipid traits: apo A1 (N=115,082), apo B (N=115,082), HDL-C (N=115,082), LDL-C (N=115,082), and TG (N =115,082) (23).”
Mendelian randomization with proxy exposures: challenges and opportunities
Rahu, I., Tambets, R., Fauman, E. B., & Alasoo, K. (2025) · Genetics · doi:10.1093/genetics/iyaf210 · Cited by 8
Human genetic variation determines 24-hour rhythmic gene expression and disease risk
Chen, Y., Liu, P., Sabo, A., & Guan, D. (2025) · Nature Communications · doi:10.1038/s41467-025-59524-5 · Cited by 11
“The strati fi ed LDSC regression was used to quantify the heritability attributable to rhyQTLs and eQTLs for the 15 lipid or lipoprotein-relatedtraits 40,41,74,75 .”
Genetics-based risk scores for prediction of premature coronary artery disease
Gupta, R. (2023) · Indian Heart Journal · doi:10.1016/j.ihj.2023.08.003 · Cited by 7
“42 In recent years, identi fi cation of PCSK9 gene, 43 has led to more ef fi cient LDL cholesterol lowering with PCSK9 inhibiting monoclonal antibodies (evolocumab, alir-ocumab, inclisiran, etc).”
BackgroundLiu, J., Ying, J., & Hu, T. (2024) · Postgraduate Medical Journal · doi:10.1093/postmj/qgae017 · Cited by 7
Xie, Y., Wu, Y., Tao, Q., Chen, Y., & Zeng, C. (2024) · Journal of Cancer · doi:10.7150/jca.96085 · Cited by 7
“The glutamine -associated genetic variants used in our study were derived from a GWAS analysis consisting of up to 114751 mixed populations containing 11590399 SNPs [20].”
MethodXu, T., Liu, C., Ning, X., Gao, Z., Li, A., Wang, S., Leng, L., Kong, P., Liu, P., Zhang, S., et al. (2024) · BMC Pulmonary Medicine · doi:10.1186/s12890-024-03275-4 · Cited by 7
“Summary statistics related to glutamine levels were obtained from the GWAS data [23], which included 114,751 subjects (https://gwas. mrcieu.ac.uk/).”
MethodYe, F., Huang, Y., Zeng, L., Li, N., Hao, L., Yue, J., Li, S., Deng, J., Yu, F., & Hu, X. (2024) · Clinical Nutrition · doi:10.1016/j.clnu.2024.09.044 · Cited by 8
Ma, Z., Zhang, R., Yuan, D., Yu, C., Baranova, A. V., Cao, H., & Zhang, F. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.03.032 · Cited by 7
Serum amino acid alterations in hyperuricemia: potential targets for renal disease prevention
Sheng, Q., Ma, Y., Geng, B., Chen, J., Cheng, J., Liu, S., Li, R. Q., Li, X., Wang, J., Lu, H., et al. (2025) · Amino Acids · doi:10.1007/s00726-025-03444-7 · Cited by 7
“…isoleucine (Ile), leucine (Leu), phenylalanine (Phe), tyrosine (Tyr), and valine (Val) were sourced from a study conducted by Richardson TG in 2021(Richardson et al. 2022), data of arginine (Arg), asparagine (Asn), aspartic acid (Asp), cysteine (Cys), glutamine (Glu), lysine (Lys), methionine…”
Interplay between age, APOE Ɛ4 and the metabolome in plasma and brain in Alzheimer’s disease
Amin, N., Liu, J., Sproviero, W., Arnold, M., Batra, R., Bonnechère, B., Chiou, Y., Fernandes, M., Krumsiek, J., Newby, D., et al. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03625-8 · Cited by 9
“The instruments for the metabolites were extracted from the largest GWAS of nightingale metabolites by Richardson et al. [29].”
bubbleHeatmap: an R package for visualization of Nightingale Health metabolomics datasets
Boxall, R., Holmes, M. V., & Walters, R. G. (2023) · Bioinformatics Advances · doi:10.1093/bioadv/vbad123 · Cited by 6
Self-citationRamadan, F. A., Arani, G., Jafri, A., Thompson, T., Bland, V. L., Renquist, B. J., Raichlen, D. A., Alexander, G. E., & Klimentidis, Y. C. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-231063 · Cited by 6
Miao, Y., Gan, J., Ni, Y.-J., Zhang, Z., Yu, L.-X., Quan, W., Zhang, Z., Wang, H., Han, S., Qu, F.-Y., et al. (2025) · International Journal of Surgery · doi:10.1097/js9.0000000000002506 · Cited by 9
Sun, Y., Xu, H., & Ye, K. (2025) · Human Genetics and Genomics Advances · doi:10.1016/j.xhgg.2025.100470 · Cited by 11
Metadata
- Authors
- Richardson, T. G., Leyden, G. M., Wang, Q., Bell, J. A., Elsworth, B., Davey Smith, G., & Holmes, M. V.
- Affiliations
- University of Bristol (GB)
- University of Oxford (GB)
- Corresponding author
- Richardson, Tom G.
- ORCID
- Venue
- PLOS Biology
- Publisher
- Public Library of Science (PLoS)
- Published
- 2022-02-25
- Volume
- 20
- Issue
- 2
- Pages
- e3001547
- ISSN
- 1544-9173 (ISSN-L)
- 1545-7885
- PMC
- PMC8906647
- OpenAlex
- W4214506665
- Cited by
- 304
- References
- 51
- Citations by year
- 2026: 52 · 2025: 103 · 2024: 95 · 2023: 41 · 2022: 12
- FWCI
- 60.45
- Type
- journal article
- Language
- en
- Update notices
- new_version (2022-03-09)
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS Biology (publishedVersion, cc-by)
- medRxiv (acceptedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Bristol Research (University of Bristol) (publishedVersion, cc-by-nc)
- Explore Bristol Research (publishedVersion, cc-by-nc)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- British Heart Foundation (FS/18/23/33512)
- Medical Research Council (MC_UU_00011/1)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolomics and Mass Spectrometry Studies
- Keywords
- lipid therapy, Mendelian randomization, blood metabolome, coronary artery disease risk, LDL cholesterol lowering, triglyceride lowering, HMGCR, PCSK9, NPC1L1, cholesteryl ester transfer protein, apolipoprotein C-III, ANGPTL3, ANGPTL4, lipoprotein lipase, glycoprotein acetyls, inflammatory markers, metabolic phenotypes, treatment response biomarkers
- MeSH terms
- Proprotein Convertase 9, Angiopoietin-like Proteins, Angiopoietin-Like Protein 3, Cholesterol, Humans, Lipoproteins, Cholesterol, HDL, Cholesterol, LDL, Triglycerides, Mendelian Randomization Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.